
Cancer Registry Software Market Showcase Noteworthy CAGR 10.7% In Global Market Forecast Till 2024
Global Cancer Registry Software Market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.
The Global Cancer Registry Software Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.
We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12958
Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Cancer Registry Software Market.
The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.
The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).
Key Takeaways:
What is the market size in 2018 and the growth rate of the Global Cancer Registry Software Market?
What is the market drivers, restrains, opportunities governing the Global Cancer Registry Software Market?
Which are the largest and the fastest growing segments in the Global Cancer Registry Software Market?
Who are the key players operating in the market and their market position?
What is the pipeline scenario, drug pricing analysis and technological development in the market?
View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/cancer-registry-software-market-mrf-12958
Global Cancer Registry Software Market Research Report By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) - Forecast till 2024
Market Scenario
The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period. Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.
On the other hand, privacy and data security-related concerns and reluctance to adopt advanced solutions are likely to hamper the growth of the market.
Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality, and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of the database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research amp; clinical studies.
The market, by end user, has been segmented into hospitals amp; medical practices, government organizations amp; research centers, pharmaceutical, biotechnology, and medical device companies, and others.
The global cancer registry software market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East amp; Africa. The cancer registry software market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European cancer registry software market has been segmented into Western Europe and Eastern Europe. Western Europe cancer registry software market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The cancer registry software market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cancer registry software market in the Middle East amp; Africa has been segmented into the Middle East and Africa.
Global Cancer Registry Software Market, by Key Players
Onco, Inc.
Rocky Mountain Cancer Data Systems
McKesson Corporation
Elekta AB (PUB)
C/Net Solutions
Electronic Registry Systems, Inc.
ROCKY MOUNTAIN CANCER DATA SYSTEMS
MCKESSON CORPORATION
ORDINAL DATA, INC
CONDUENT, INC
IBM
HIMAGINE SOLUTIONS INC
Regional Market
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the rising prevalence of cancer, innovative product development and increasing investment in research and development for innovation in the region. According to the National Cancer Institute, there were 1,735,350 new cases of cancer in the US in 2018.
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic amp; research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East amp; Africa has the least share of the global cancer registry software market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Global Cancer Registry Software Market, by Type
Integrated Software
Standalone Software
Global Cancer Registry Software Market, by Deployment Model
Cloud-Based Models
On-Premise Models
Global Cancer Registry Software Market, by Database Type
Commercial Databases
Public Databases
Global Cancer Registry Software Market, by Functionality
Patient Care Management
Product Outcome Evaluation
Cancer Reporting to Meet State and Federal Regulations
Medical Research amp; Clinical Studies
Global Cancer Registry Software Market, by End User
Hospitals amp; Medical Practices
Government Organizations amp; Research Centers
Pharmaceutical, Biotechnology, and Medical Device Companies
Others
Global Cancer Registry Software Market, by Region
Americas
North America
US
Canada
Latin America
Europe
Western Europe
Germany
France
Italy
Spain
UK
Rest of Western Europe
Eastern Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
The Middle East amp; Africa
Middle East
Africa
Intended Audience
Software companies
Contract research organizations
Academic and research institutes
Government associations
Table Of Contents
Cancer Registry Software Market Research Report - Global Forecast till 2024
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porterrsquo;s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Cancer Registry Software Market, By Type
6.1 Introduction
6.2 Integrated Software
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
6.3 Standalone Software
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
Chapter 7. Global Cancer Registry Software Market, By Deployment Model
7.1 Introduction
7.2 Cloud-Based Models
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
7.3 On-Premise Models
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
Chapter 8. Global Cancer Registry Software Market, By Database Type
8.1 Introduction
8.2 Commercial Databases
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
8.3 Public Databases
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
Chapter 9. Global Cancer Registry Software Market, By Functionality
9.1 Introduction
9.2 Patient Care Management
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
9.3 Product Outcome Evaluation
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
9.4 Cancer Reporting To Meet State And Federal Regulations
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
9.5 Medical Research amp; Clinical Studies
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
Chapter 10. Global Cancer Registry Software Market, By End User
10.1 Introduction
10.2 Hospitals amp; Medical Practices
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
10.3 Pharmaceutical, Biotechnology, And Medical Device Companies
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
10.4 Government Organizations amp; Research Centers
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
10.5 Others
Market Estimates amp; Forecast, By Region, 2019ndash;2024
Market Estimates amp; Forecast, By Country, 2019ndash;2024
Chapter 11. Global Cancer Registry Software Market, By Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.1.1 US
11.1.2 Canada
11.2.2 Latin America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 UK
11.3.1.6 Rest Of Western Europe
11.3.2 Eastern Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest Of Asia-Pacific
11.5 Middle East amp; Africa
11.5.1 Middle East
11.5.2 Africa
Chapter 12. Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development amp; Strategies
Chapter 13. Company Profiles
13.1 Onco, Inc.
13.1.1 Company Overview
13.1.2 Type Overview
13.1.3 Financials Overview
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Rocky Mountain Cancer Data Systems
13.2.1 Company Overview
13.2.2 Type Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Elekta AB (PUB)
13.3.1 Company Overview
13.3.2 Type Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 C/Net Solutions
13.4.1 Company Overview
13.4.2 Type Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 Electronic Registry Systems, Inc.
13.5.1 Company Overview
13.5.2 Type Overview
13.5.3 Financial Overview
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 MCKESSON CORPORATION
13.6.1 Company Overview
13.6.2 Type Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 ORDINAL DATA, INC
13.7.1 Overview
13.7.2 Type Overview
13.7.3 Financial Overview
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 CONDUENT, INC
13.8.1 Overview
13.8.2 Type Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 IBM
13.9.1 Overview
13.9.2 Type Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 HIMAGINE SOLUTIONS INC
13.10.1 Overview
13.10.2 Type Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Others
Chapter 14 Conclusion
14.1 Key Findings
14.1.1 From CEOrsquo;s Viewpoint
14.1.2 Unmet Needs Of The Market
14.2 Key Companies To Watch
14.3 Predictions For The Cancer Registry Software Industry
Chapter 15. Appendix
Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12958
About Us:
Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Contact:
Email: sales@amecoresearch.com | +1 407 915 4157
Editor Details
-
Company:
- Wired Hearld
- Website: